Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 8 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Leukoplakia, Oral 2 Erythroplasia 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 TP53 Y220C Mutation 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Prediabetic State 1 Posterior Fossa Ependymal Tumor 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms by Site 1 Neoplasms 1 Mouth Neoplasms 1 Metabolic Diseases 1 Melanoma 1 Medulloblastoma 1 Insulin Resistance 1 Infertility 1 Hyperplasia 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1

Interventions

mazdutide 1 lime 1 fasudil 1 Tablets 1 Referral and Consultation 1 Ramipril 1 Radiosurgery 1 Metformin 1 Mental Status and Dementia Tests 1 Memantine 1 Health 1 Exercise 1 Acetylcysteine 1 Accidental Falls 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Metformin × 90 days × Clear all

NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡